Mechanisms involved in cholesterol-induced neuronal insulin resistance

Neuropharmacology

Volumn 57, Issue 3, 2009, Pages 268-276

  Taghibiglou, Changiz ^a   Bradley, Clarrisa A ^a   Gaertner, Tara ^a   Li, Yuping ^a   Wang, Yushan ^a   Wang, Yu Tian ^a  

^a VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Cholesterol; Cortical neurons; Insulin receptor; Insulin resistance; Lipid rafts; Trafficking

Indexed keywords

CHOLESTEROL; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN TYROSINE PHOSPHATASE; TYROSINE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; ENZYME ACTIVITY; INSULIN RESISTANCE; LIPID RAFT; MOUSE; NERVE CELL MEMBRANE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL CORTEX; CHOLESTEROL; ENDOCYTOSIS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MEMBRANE MICRODOMAINS; NEURONS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 67650650466     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.05.013     Document Type: Article

References (88)

1. Allen J.A., Halverson-Tamboli R.A., and Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 8 (2007) 128-140
2. Arase K., Fisler J.S., Shargill N.S., York D.A., and Bray G.A. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. Am. J. Physiol. 255 (1988) R974-R981
3. Babuke T., and Tikkanen R. Dissecting the molecular function of reggie/flotillin proteins. Eur. J. Cell Biol. 86 (2007) 525-532
4. Balbis A., Baquiran G., Mounier C., and Posner B.I. Effect of insulin on caveolin-enriched membrane domains in rat liver. J. Biol. Chem. 279 (2004) 39348-39357
5. Bari M., Oddi S., De Simone C., Spagnolo P., Gasperi V., Battista N., Centonze D., and Maccarrone M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 54 (2008) 45-50
6. Bickel P.E. Lipid rafts and insulin signaling. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1-E10
7. Bickel P.E., Scherer P.E., Schnitzer J.E., Oh P., Lisanti M.P., and Lodish H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272 (1997) 13793-13802
8. Braunton J.L., Wong V., Wang W., Salter M.W., Roder J., Liu M., and Wang Y.T. Reduction of tyrosine kinase activity and protein tyrosine dephosphorylation by anoxic stimulation in vitro. Neuroscience 82 (1998) 161-170
9. Brown D.A. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21 (2006) 430-439
10. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
11. Capeau J., Lascols O., Flaig-Staedel C., Blivet M.J., Beck J.P., and Picard J. Degradation of insulin receptors by hepatoma cells: insulin-induced down-regulation results from an increase in the rate of basal receptor degradation. Biochimie 67 (1985) 1133-1141
12. Ceresa B.P., Kao A.W., Santeler S.R., and Pessin J.E. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol. Cell Biol. 18 (1998) 3862-3870
13. Cheng A., Dube N., Gu F., and Tremblay M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem. 269 (2002) 1050-1059
14. Clegg D.J., Benoit S.C., Reed J.A., Woods S.C., Dunn-Meynell A., and Levin B.E. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R981-R986
15. de la Monte S.M., and Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J. Alzheimer's Dis. 7 (2005) 45-61
16. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., Saad M.J., and Velloso L.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146 (2005) 4192-4199
17. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 86 (2006) 465-514
18. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., and Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103 (1999) 253-259
19. Fra A.M., Williamson E., Simons K., and Parton R.G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8655-8659
20. Freeman D.J., Norrie J., Sattar N., Neely R.D., Cobbe S.M., Ford I., Isles C., Lorimer A.R., Macfarlane P.W., McKillop J.H., Packard C.J., Shepherd J., and Gaw A. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103 (2001) 357-362
21. Gielen E., Baron W., Vandeven M., Steels P., Hoekstra D., and Ameloot M. Rafts in oligodendrocytes: evidence and structure-function relationship. Glia 54 (2006) 499-512
22. Goldstein B.J. Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. J. Clin. Endocrinol. Metab. 87 (2002) 2474-2480
23. Havrankova J., Roth J., and Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272 (1978) 827-829
24. Hering H., Lin C.C., and Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23 (2003) 3262-3271
25. Horvath E.M., Tackett L., and Elmendorf J.S. A novel membrane-based anti-diabetic action of atorvastatin. Biochem. Biophys. Res. Commun. 372 (2008) 639-643
26. Hou Q., Huang Y., Amato S., Snyder S.H., Huganir R.L., and Man H.Y. Regulation of AMPA receptor localization in lipid rafts. Mol. Cell Neurosci. 38 (2008) 213-223
27. Ikonen E., and Vainio S. Lipid microdomains and insulin resistance: is there a connection?. Sci. STKE 2005 (2005) pe3
28. Irani B.G., Dunn-Meynell A.A., and Levin B.E. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 148 (2007) 310-316
29. Jury E.C., Kabouridis P.S., Flores-Borja F., Mageed R.A., and Isenberg D.A. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113 (2004) 1176-1187
30. Kabayama K., Sato T., Kitamura F., Uemura S., Kang B.W., Igarashi Y., and Inokuchi J. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 15 (2005) 21-29
31. Kong M.M., Hasbi A., Mattocks M., Fan T., O'Dowd B.F., and George S.R. Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol. Pharmacol. 72 (2007) 1157-1170
32. Korade Z., and Kenworthy A.K. Lipid rafts, cholesterol, and the brain. Neuropharmacology 55 (2008) 1265-1273
33. Lalli C.A., Pauli J.R., Prada P.O., Cintra D.E., Ropelle E.R., Velloso L.A., and Saad M.J. Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. Metabolism 57 (2008) 57-65
34. Le P.U., Guay G., Altschuler Y., and Nabi I.R. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem. 277 (2002) 3371-3379
35. Levin B.E. Factors promoting and ameliorating the development of obesity. Physiol. Behav. 86 (2005) 633-639
36. Levin B.E., and Dunn-Meynell A.A. Reduced central leptin sensitivity in rats with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R941-R948
37. Lim K.I., and Yin J. Localization of receptors in lipid rafts can inhibit signal transduction. Biotechnol. Bioeng. 90 (2005) 694-702
38. Ma L., Huang Y.Z., Pitcher G.M., Valtschanoff J.G., Ma Y.H., Feng L.Y., Lu B., Xiong W.C., Salter M.W., Weinberg R.J., and Mei L. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci. 23 (2003) 3164-3175
39. Man H.Y., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., and Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25 (2000) 649-662
40. Mangaloglu L., Cheung R.C., Van Iderstine S.C., Taghibiglou C., Pontrelli L., and Adeli K. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity. Metabolism 51 (2002) 409-418
41. Mansuy I.M., and Shenolikar S. Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends Neurosci. 29 (2006) 679-686
42. Meier D.A., Hennes M.M., McCune S.A., and Kissebah A.H. Effects of obesity and gender on insulin receptor expression in liver of SHHF/Mcc-FAcp rats. Obes. Res. 3 (1995) 465-470
43. Michel V., and Bakovic M. Lipid rafts in health and disease. Biol. Cell 99 (2007) 129-140
44. Mielke J.G., Taghibiglou C., Liu L., Zhang Y., Jia Z., Adeli K., and Wang Y.T. A biochemical and functional characterization of diet-induced brain insulin resistance. J. Neurochem. 93 (2005) 1568-1578
45. Mielke J.G., Taghibiglou C., and Wang Y.T. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience 143 (2006) 165-173
46. Munzberg H., Flier J.S., and Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 (2004) 4880-4889
47. Musi N., and Goodyear L.J. Insulin resistance and improvements in signal transduction. Endocrine 29 (2006) 73-80
48. Naples M., Federico L.M., Xu E., Nelken J., and Adeli K. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization. Atherosclerosis 198 (2008) 94-103
49. Ohira K., Maekawa S., and Hayashi M. Absence of TrkB and insulin receptor beta in the triton insoluble low-density fraction (raft). Neuroreport 11 (2000) 1307-1311
50. Pihlajamaki J., Gylling H., Miettinen T.A., and Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J. Lipid Res. 45 (2004) 507-512
51. Pike L.J., and Casey L. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41 (2002) 10315-10322
52. Pirola L., Johnston A.M., and Van Obberghen E. Modulation of insulin action. Diabetologia 47 (2004) 170-184
53. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
54. Posey K., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., Pennathur S., Baskin D.G., Heinecke J.W., Woods S.C., Schwartz M.W., and Niswender K.D. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. (2008)
55. Roepstorff K., Thomsen P., Sandvig K., and van Deurs B. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J. Biol. Chem. 277 (2002) 18954-18960
56. Saltiel A.R., and Pessin J.E. Insulin signaling in microdomains of the plasma membrane. Traffic 4 (2003) 711-716
57. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kustermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., and Bruning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3100-3105
58. Semenkovich C.F. Insulin resistance and atherosclerosis. J. Clin. Invest. 116 (2006) 1813-1822
59. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
60. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
61. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., and de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?. J. Alzheimer's Dis. 7 (2005) 63-80
62. Taghibiglou C., Carpentier A., Van Iderstine S.C., Chen B., Rudy D., Aiton A., Lewis G.F., and Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275 (2000) 8416-8425
63. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., Le-Tien H., Fantus I.G., Lewis G.F., and Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J. Biol. Chem. 277 (2002) 793-803
64. Taylor S.I., Samuels B., Roth J., Kasuga M., Hedo J.A., Gorden P., Brasel D.E., Pokora T., and Engel R.R. Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J. Clin. Endocrinol. Metab. 54 (1982) 919-930
65. Tomioka M., Adachi T., Suzuki H., Kunitomo H., Schafer W.R., and Iino Y. The insulin/PI 3-kinase pathway regulates salt chemotaxis learning in Caenorhabditis elegans. Neuron 51 (2006) 613-625
66. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7 (2006) 833-846
67. Tsui-Pierchala B.A., Encinas M., Milbrandt J., and Johnson Jr. E.M. Lipid rafts in neuronal signaling and function. Trends Neurosci. 25 (2002) 412-417
68. Uhles S., Moede T., Leibiger B., Berggren P.O., and Leibiger I.B. Isoform-specific insulin receptor signaling involves different plasma membrane domains. J. Cell Biol. 163 (2003) 1327-1337
69. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 53 (2002) 319-336
70. Vainio S., Bykov I., Hermansson M., Jokitalo E., Somerharju P., and Ikonen E. Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes. Biochem. J. 391 (2005) 465-472
71. Vainio S., Heino S., Mansson J.E., Fredman P., Kuismanen E., Vaarala O., and Ikonen E. Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO Rep. 3 (2002) 95-100
72. van der Heide L.P., Ramakers G.M., and Smidt M.P. Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 79 (2006) 205-221
73. Wada A., Yokoo H., Yanagita T., and Kobayashi H. New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J. Pharmacol. Sci. 99 (2005) 128-143
74. Wan Q., Xiong Z.G., Man H.Y., Ackerley C.A., Braunton J., Lu W.Y., Becker L.E., MacDonald J.F., and Wang Y.T. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388 (1997) 686-690
75. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., and Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron 38 (2003) 915-928
76. Wang Y.T., and Linden D.J. Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis. Neuron 25 (2000) 635-647
77. Weickert M.O., and Pfeiffer A.F. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49 (2006) 1732-1741
78. Weinberg J.M. Lipotoxicity. Kidney Int. 70 (2006) 1560-1566
79. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
80. Williams G., Cai X.J., Elliott J.C., and Harrold J.A. Anabolic neuropeptides. Physiol. Behav. 81 (2004) 211-222
81. Wong V., Stavar L., Szeto L., Uffelman K., Wang C.H., Fantus I.G., and Lewis G.F. Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. Atherosclerosis 184 (2006) 348-355
82. Wu C., Butz S., Ying Y., and Anderson R.G. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem. 272 (1997) 3554-3559
83. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., and Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
84. Zhang X., Zhang G., Zhang H., Karin M., Bai H., and Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135 (2008) 61-73
85. Zhao H., Dupont J., Yakar S., Karas M., and LeRoith D. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells. Oncogene 23 (2004) 786-794
86. Zhao W.Q., Chen H., Quon M.J., and Alkon D.L. Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490 (2004) 71-81
87. Zhao W.Q., De Felice F.G., Fernandez S., Chen H., Lambert M.P., Quon M.J., Krafft G.A., and Klein W.L. Amyloid beta oligomers induce impairment of neuronal insulin receptors. Faseb J. 22 (2008) 246-260
88. Zhu D., Xiong W.C., and Mei L. Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering. J. Neurosci. 26 (2006) 4841-4851